Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"
Gespeichert in:
| Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2012-01, Vol.125 (3), p.e291; author reply e293-e291; author reply e294 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e291; author reply e294 |
|---|---|
| container_issue | 3 |
| container_start_page | e291; author reply e293 |
| container_title | Circulation (New York, N.Y.) |
| container_volume | 125 |
| creator | Reynolds, Stephanie Parra, David Rosenstein, Robert S |
| description | |
| doi_str_mv | 10.1161/CIRCULATIONAHA.111.056077 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_917855357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>917855357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-9ec7e58df4eb4c070a38b33fdf57be3f6625e10ce523826e99efef67335b8f5d3</originalsourceid><addsrcrecordid>eNpVUlGL1DAQrofirad_QeK9qGDPptk0rW9lWb2F4kHZe_CppO2kG02TmqQe9deb3T0FYSCZ-b5vvgmZKHqDkxuMM_xxs6s391W53919LW_LUMM3Cc0Sxi6iFabpOl5TUjyNVkmSFDEjaXoZvXDue0gzwujz6DJNU4ZzylZPLirwHixqF1TDoo3qHQKPuEIWBm57qQfErZedgg_oupbuBzICtQrgBD1If0Ap6o0DdwR63sqBe8s16sw4cQv9mfPAreBWahQimARHrnu0mFkP4T5xL0F7d-YGvQwDCNlaqVSAjP4U6CG4Wpw8GfkDoDq0MKP8HTy2v7iaT8wjWBk9xHuwIyp1GN3wYVZce7Q_gOXTgt7V27j69h6dfK5fRs8EVw5ePZ5X0f3n7X5zG1d3X3absoo7kjEfF9AxoHkv1tCuu4QlnOQtIaIXlLVARJalFHDSAU1JnmZQFCBAZIwQ2uaC9uQqenvuO1nzcwbnm1G6DsILNZjZNQVmOaWEssAszszOGucsiGaycuR2aXDSHDeg-X8DQg035w0I2tePLnM7Qv9P-ffLyR-qHbL5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>917855357</pqid></control><display><type>article</type><title>Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Reynolds, Stephanie ; Parra, David ; Rosenstein, Robert S</creator><creatorcontrib>Reynolds, Stephanie ; Parra, David ; Rosenstein, Robert S</creatorcontrib><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.111.056077</identifier><identifier>PMID: 22271857</identifier><language>eng</language><publisher>United States</publisher><subject>Anticoagulants - adverse effects ; Atrial Fibrillation - drug therapy ; Benzimidazoles - adverse effects ; beta-Alanine - analogs & derivatives ; Female ; Hemorrhage - chemically induced ; Humans ; Male ; Warfarin - adverse effects</subject><ispartof>Circulation (New York, N.Y.), 2012-01, Vol.125 (3), p.e291; author reply e293-e291; author reply e294</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-9ec7e58df4eb4c070a38b33fdf57be3f6625e10ce523826e99efef67335b8f5d3</citedby><cites>FETCH-LOGICAL-c367t-9ec7e58df4eb4c070a38b33fdf57be3f6625e10ce523826e99efef67335b8f5d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,3688,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22271857$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reynolds, Stephanie</creatorcontrib><creatorcontrib>Parra, David</creatorcontrib><creatorcontrib>Rosenstein, Robert S</creatorcontrib><title>Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><subject>Anticoagulants - adverse effects</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Benzimidazoles - adverse effects</subject><subject>beta-Alanine - analogs & derivatives</subject><subject>Female</subject><subject>Hemorrhage - chemically induced</subject><subject>Humans</subject><subject>Male</subject><subject>Warfarin - adverse effects</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUlGL1DAQrofirad_QeK9qGDPptk0rW9lWb2F4kHZe_CppO2kG02TmqQe9deb3T0FYSCZ-b5vvgmZKHqDkxuMM_xxs6s391W53919LW_LUMM3Cc0Sxi6iFabpOl5TUjyNVkmSFDEjaXoZvXDue0gzwujz6DJNU4ZzylZPLirwHixqF1TDoo3qHQKPuEIWBm57qQfErZedgg_oupbuBzICtQrgBD1If0Ap6o0DdwR63sqBe8s16sw4cQv9mfPAreBWahQimARHrnu0mFkP4T5xL0F7d-YGvQwDCNlaqVSAjP4U6CG4Wpw8GfkDoDq0MKP8HTy2v7iaT8wjWBk9xHuwIyp1GN3wYVZce7Q_gOXTgt7V27j69h6dfK5fRs8EVw5ePZ5X0f3n7X5zG1d3X3absoo7kjEfF9AxoHkv1tCuu4QlnOQtIaIXlLVARJalFHDSAU1JnmZQFCBAZIwQ2uaC9uQqenvuO1nzcwbnm1G6DsILNZjZNQVmOaWEssAszszOGucsiGaycuR2aXDSHDeg-X8DQg035w0I2tePLnM7Qv9P-ffLyR-qHbL5</recordid><startdate>20120124</startdate><enddate>20120124</enddate><creator>Reynolds, Stephanie</creator><creator>Parra, David</creator><creator>Rosenstein, Robert S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120124</creationdate><title>Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"</title><author>Reynolds, Stephanie ; Parra, David ; Rosenstein, Robert S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-9ec7e58df4eb4c070a38b33fdf57be3f6625e10ce523826e99efef67335b8f5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anticoagulants - adverse effects</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Benzimidazoles - adverse effects</topic><topic>beta-Alanine - analogs & derivatives</topic><topic>Female</topic><topic>Hemorrhage - chemically induced</topic><topic>Humans</topic><topic>Male</topic><topic>Warfarin - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reynolds, Stephanie</creatorcontrib><creatorcontrib>Parra, David</creatorcontrib><creatorcontrib>Rosenstein, Robert S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reynolds, Stephanie</au><au>Parra, David</au><au>Rosenstein, Robert S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2012-01-24</date><risdate>2012</risdate><volume>125</volume><issue>3</issue><spage>e291; author reply e293</spage><epage>e291; author reply e294</epage><pages>e291; author reply e293-e291; author reply e294</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><cop>United States</cop><pmid>22271857</pmid><doi>10.1161/CIRCULATIONAHA.111.056077</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-7322 |
| ispartof | Circulation (New York, N.Y.), 2012-01, Vol.125 (3), p.e291; author reply e293-e291; author reply e294 |
| issn | 0009-7322 1524-4539 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_917855357 |
| source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
| subjects | Anticoagulants - adverse effects Atrial Fibrillation - drug therapy Benzimidazoles - adverse effects beta-Alanine - analogs & derivatives Female Hemorrhage - chemically induced Humans Male Warfarin - adverse effects |
| title | Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial" |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T20%3A45%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20by%20Reynolds%20et%20al%20regarding%20article,%20%22Risk%20of%20bleeding%20with%202%20doses%20of%20dabigatran%20compared%20with%20warfarin%20in%20older%20and%20younger%20patients%20with%20atrial%20fibrillation:%20an%20analysis%20of%20the%20Randomized%20Evaluation%20of%20Long-Term%20Anticoagulant%20Therapy%20(RE-LY)%20trial%22&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Reynolds,%20Stephanie&rft.date=2012-01-24&rft.volume=125&rft.issue=3&rft.spage=e291;%20author%20reply%20e293&rft.epage=e291;%20author%20reply%20e294&rft.pages=e291;%20author%20reply%20e293-e291;%20author%20reply%20e294&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.111.056077&rft_dat=%3Cproquest_cross%3E917855357%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=917855357&rft_id=info:pmid/22271857&rfr_iscdi=true |